• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 3; INTEGRATED CONTINUOUS GLUCOSE MONITORING SYSTEM, FACTORY CALIBRATED, NOT FOR USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 3; INTEGRATED CONTINUOUS GLUCOSE MONITORING SYSTEM, FACTORY CALIBRATED, NOT FOR USE Back to Search Results
Device Problems Low Readings (2460); Device Sensing Problem (2917)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/03/2023
Event Type  malfunction  
Event Description
The freestyle libre 3 has failed the last 4 sensors i have applied.It reported normal levels the first day and then reported low glucose readings such as 53 when my finger stick was 123.Each one lasted 4-5 days and then i was informed that the sensor no longer worked.An error code of 365 was given on each sensor.I reported it to the company and they sent me a replacement but they are supposed to last 14 days.I used the libre 2 also and had 8 out of 10 stop working early and give false hypoglycemic events.The failure rate is too high and it caused me to eat more carbs, and have high glucose levels that were not being recorded by the sensors.Reference reports mw5116380, mw5116382, mw5116383.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 3
Type of Device
INTEGRATED CONTINUOUS GLUCOSE MONITORING SYSTEM, FACTORY CALIBRATED, NOT FOR USE
Manufacturer (Section D)
ABBOTT DIABETES CARE INC.
MDR Report Key16689453
MDR Text Key312936093
Report NumberMW5116381
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
BUPRENORPHINE; CALCIUM; CITALOPRAM; DEXILANT; DOCUSATE; DRONABINOL ; ESTRADIOL ; FAMOTIDINE; FEXOFENADINE; IRON ; LEVOTHYROXINE; LIOTHYHRONINE; LISINOPRIL ; METFORMIN ; METOCLOPRAMIDE; ORPHENADRINE; PIOGLITAZONE; ROSUVASTATIN ; SENNA; TRULICITY; VITAMIN B; VITAMIN D; ZOLPIDEM
Patient Age61 YR
Patient SexFemale
Patient Weight75 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-